Zepp Health (ZEPP) Q1 FY26 earnings call

Zepp frames the quarter as structural validation of its premiumization and hybrid-training platform thesis — mix, pricing power and brand authority compounding enough to expand margins even into a memory-cost inflection. The exclusive HYROX partnership shifts positioning from device seller toward training platform. The near-term test is absorbing memory inflation and launch phasing while holding the stated path to full-year profitable growth.